Fresh Medical Laboratories
Salt Lake City, US · Delaware corporation
Find your way into Fresh Medical Laboratories
302 people in our graph share verified history with the Fresh Medical Laboratories team — schools, employers, funds. One of them is your warm intro.
Tracy Georgeunlockedknows Michael Garff · together at ARUP Laboratories (overlapped)
×2knows the team · via ARUP Laboratories
knows the team · via Lassonde Entrepreneur Institute
×8knows the team · via U.S. Bank
Founders & leadership
SC
Steven C ErorExecutive
MG

Michael GarffExecutiveMichael Garff is an Executive Officer at Fresh Medical Laboratories, which develops data visualization tools to help hospitals reduce unnecessary blood transfusions. He previously held leadership roles at IONIQ Sciences, where he contributed to FDA Breakthrough designation and CE Mark approval, manufacturing setup, and quality management system implementation, and earlier worked in organizational development at the Pierre Lassonde Entrepreneur Center, US Bank, and the University of Utah's Biomedical Informatics Department.
Board
DT
Dennis TulaneBoard director
TT
Tim TreuBoard director
RR
Robert RaybouldBoard director
RM
Richard McKeownBoard director
CC
Clark CampbellBoard director
WA
Wayne AdamsBoard director
TM
Todd MorganBoard director
Reported raises · per SEC filings
Form D private placements$7.3M disclosed across 4 of 5 rounds · 2015–2020
▶$182KraisedDec 2020 · 4 investors · BiotechnologyRule 506(b)
▶$182KraisedDec 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Garff MichaelExecutive Officer, Director
- Jared BauerExecutive Officer
- Don PattersonDirector
- Jim HoganDirector
- David NielsenDirector
- Offering amount
- $6M
- Amount sold
- $182K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$824KraisedMar 2018 · 4 investors · BiotechnologyRule 506(c)
▶$824KraisedMar 2018 · 4 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- J Scott NixonDirector
- Robin L SmithDirector
- Todd M MorganDirector
- Michael A GarffExecutive Officer
- Robert W RaybouldDirector
- John C RuckdeschelDirector
- Steven C ErorExecutive Officer, Director
- Neil BerkleyDirector
- Mark V AndersonExecutive Officer
- Offering amount
- $3M
- Amount sold
- $824K
- Minimum investment
- $25K
- Sales commissions
- $300K
- Placement agents
- Weild & Co.
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$5MraisedMay 2017 · 160 investors · BiotechnologyRule 506(b)
▶$5MraisedMay 2017 · 160 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert W. RaybouldDirector
- Richard B. McKeownDirector
- Jeffrey S. O'DriscollDirector
- Clark A. CampbellDirector
- John C RuckdeschelDirector
- Robin L. SmithDirector
- J. Scott NixonDirector
- Michael A. GarffExecutive Officer
- Aaron W StoutExecutive Officer
- Todd M. MorganDirector
- Steven C. ErorExecutive Officer, Director
- Offering amount
- $8.5M
- Amount sold
- $5M
- Sales commissions
- $280K
- Placement agents
- Weild & Co
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedNov 2015 · 2 investors · BiotechnologyRule 506(b)
▶$1.3MraisedNov 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven C ErorExecutive Officer
- Dennis TulaneDirector
- Jeffrey S O'DriscollDirector
- Treu TimDirector
- Robert RaybouldDirector
- Michael GarffDirector
- Richard McKeownDirector
- Todd MorganDirector
- Clark CampbellDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MofferedFeb 2015 · BiotechnologyRule 506(b)
▶$1MofferedFeb 2015 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dennis TulaneDirector
- Tim TreuDirector
- Robert RaybouldDirector
- Steven C ErorExecutive Officer, Director
- Michael GarffExecutive Officer
- Richard McKeownDirector
- Clark CampbellDirector
- Wayne AdamsDirector
- Todd MorganDirector
- Offering amount
- $1M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Fresh Medical Laboratories raised?
- Fresh Medical Laboratories has disclosed $7.3M raised across 4 of its 5 known rounds.
- Where is Fresh Medical Laboratories headquartered?
- Fresh Medical Laboratories is headquartered in Salt Lake City, US.
